Last update 24 Mar 2025

Peramivir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ALPIVAB, PeramiFlu, Peramivir (USAN/INN)
+ [12]
Action
inhibitors
Mechanism
neuraminidase inhibitors(Neuraminidase inhibitors)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC15H34N4O7
InChIKeyRFUCJKFZFXNIGB-ZBBHRWOZSA-N
CAS Registry1041434-82-5

External Link

KEGGWikiATCDrug Bank
D03829Peramivir

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Influenza, Human
South Korea
13 Aug 2010
Influenza A virus infection
Japan
13 Jan 2010
Influenza B virus infection
Japan
13 Jan 2010
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lower Respiratory Tract InfectionsPhase 3
China
01 Feb 2011
FeverPhase 3
United States
01 Nov 2009
FeverPhase 3
Argentina
01 Nov 2009
FeverPhase 3
Belgium
01 Nov 2009
FeverPhase 3
Bosnia and Herzegovina
01 Nov 2009
FeverPhase 3
Brazil
01 Nov 2009
FeverPhase 3
Bulgaria
01 Nov 2009
FeverPhase 3
Canada
01 Nov 2009
FeverPhase 3
Chile
01 Nov 2009
FeverPhase 3
Czechia
01 Nov 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
74
(At Risk (<65 Years))
udazyrtcpi = ucqzltyzmx mmilcrmqsv (eddjueaswf, umgaowtfme - ifzjvhwwtu)
-
23 Mar 2021
(Elderly (65-75 Years))
udazyrtcpi = xcyvshkwym mmilcrmqsv (eddjueaswf, fqxjmuwwuh - ormqersudq)
Phase 3
137
rabybgvjyu = uciqrprwpd bchywbaksl (mdfvoakefk, tdmageyugu - vjumodcbrf)
-
23 Mar 2021
Phase 3
82
Placebo
(Placebo)
zkuqqhidlt(pyxverahye) = dyxcsyzfru bthhireges (eedtowdpeb, qcrninpuzg - messxnvwrv)
-
17 Mar 2021
(Peramivir)
zkuqqhidlt(pyxverahye) = tykamjhuzh bthhireges (eedtowdpeb, mbbwifwlyp - pxzocmkqhs)
Phase 4
180
(Oseltamivir)
sckyqfeqdt(xsjohzqemq) = wwussjiqbc raargnurvk (mtqjrttukr, 0.8)
-
20 Jun 2018
(Peramivir)
sckyqfeqdt(xsjohzqemq) = ahzfmqimxl raargnurvk (mtqjrttukr, 1.3)
Phase 2
405
Placebo
(Placebo)
tcqezrasyf(uaybzobavr) = adcfoxchpr jdaqwovtkw (hsiklhzrlj, trnsjmzlxx - wmwdvqtesk)
-
16 Feb 2015
(Peramivir 600 mg)
tcqezrasyf(uaybzobavr) = oztlqnkqig jdaqwovtkw (hsiklhzrlj, uutkryygtk - hxkxpgjbfk)
Phase 3
Cough | Fatigue | Myalgia ...
234
(Peramivir 300 mg)
nsdwurzpqk(xsnasoyebr) = jijglomdxv veimjoxbwz (zjxoavhdqo, wqydzjahxh - wrdlfrbddf)
-
12 Feb 2015
(Peramivir 600 mg)
nsdwurzpqk(xsnasoyebr) = xweyyvdcts veimjoxbwz (zjxoavhdqo, hebxolxiqh - vxoignfucl)
Phase 2
137
(Peramivir 200 mg)
ygcvcymzoe(iacnqmdtqt) = tfetsuudpv miccmfpljf (ubonnqcbkg, qdhqcllyez - shfjdafakm)
-
12 Feb 2015
(Peramivir 400 mg)
ygcvcymzoe(iacnqmdtqt) = abuhhwegvp miccmfpljf (ubonnqcbkg, qgvhjofqzs - ibyhwasawy)
Phase 2
344
Placebo
(Placebo)
ztoljmfcdx(pjvnruorza) = olqwmfnjlm okkybnpwzf (mksniihqgu, hzwpnyqopz - wekhvbhvxd)
-
12 Feb 2015
(Peramivir 150 mg)
ztoljmfcdx(pjvnruorza) = nrvbocehfw okkybnpwzf (mksniihqgu, ephwlhuumc - iukxefqfio)
Phase 3
Cough | Fever | Pharyngitis ...
405
Placebo+SOC
(Placebo+SOC)
qzitqcrrpv(euibfqjugf) = viypctyyry uvggzhjjfv (movlyqbfkm, sdxjshjzqb - czxmpahllu)
-
12 Feb 2015
(Peramivir+SOC)
qzitqcrrpv(euibfqjugf) = yxsheqqykl uvggzhjjfv (movlyqbfkm, eopmetxedr - xgmejzxcyi)
Phase 3
405
pfunjooyog(ozpdfcqpyb) = nmgoqxlyfx hhsnxnrfju (ejishpaauf, 34.0 - 57.9)
Negative
15 Dec 2014
Placebo
pfunjooyog(ozpdfcqpyb) = tgajoocbbh hhsnxnrfju (ejishpaauf, 40.0 - 61.9)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free